44 results
Page 2 of 3
8-K
EX-99.1
6lcko5xcf80lkvj0
13 Feb 20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
9:15am
8-K
7u65l0y
13 Feb 20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
9:15am
8-K
ephmnp515 w2
11 Dec 19
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
9:00am
8-K
EX-99.1
6r2prnfw7qjd0yihbg
11 Dec 19
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
9:00am
8-K
EX-10.12
vtjme il8kf
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
DEFM14A
v7wivtf5pe mgxu4
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
br4fcy0t
11 Dec 18
Preliminary proxy related to merger
5:23pm
8-K
EX-10.1
d8zhuwdm8ewil6vfh50
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
CORRESP
5sv5d pjh4wl21qwp33t
2 May 18
Correspondence with SEC
12:00am
DEF 14A
w4e8r1qe
30 Apr 18
Definitive proxy
7:02am
10-K
t8pw9zt1xf 7f473nd
1 Mar 18
Annual report
12:00am
10-Q
d6upu4pt6zmugs53l
12 May 17
Quarterly report
12:00am
10-12G/A
lofk lwfmuv95m
13 Mar 17
Registration of securities (amended)
12:00am